Brainstorm Cell (BCLI)
1.4500 -0.0600 (-3.97%)
Brainstorm Cell Therapeutics is a biotechnology company focused on developing innovative therapies aimed at treating neurodegenerative diseases and neurological conditions through the harnessing of stem cell technology. The company is particularly known for its research and development of treatments using its proprietary approach to generating cells that can potentially repair or regenerate damaged tissues in the central nervous system. By leveraging its expertise in cellular therapy, Brainstorm Cell aims to provide new hope for patients suffering from debilitating disorders. Through ongoing clinical trials and research initiatives, the company is committed to advancing its scientific discoveries into effective treatment options.
Previous Close | 1.510 |
---|---|
Open | 1.550 |
Bid | 1.400 |
Ask | 1.540 |
Day's Range | 1.420 - 1.630 |
52 Week Range | 1.050 - 11.89 |
Volume | 46,458 |
Market Cap | 8.27M |
PE Ratio (TTM) | 0.4328 |
EPS (TTM) | 3.4 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 98,294 |